61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Tais Basaco Bernabeu; Rosalba Mansi; Luigi Del Pozzo; Sandra Zanger; Raghuvir H. Gaonkar; Lisa McDougall; Francesco De Rose; Leila Jaafar-Thiel; Michael Herz; Matthias Eiber; Gary A. Ulaner; Wolfgang A. Weber; Melpomeni Fani

doi:10.2967/jnumed.123.267126

Research ArticleBasic Science Investigation

Open Access

⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, Sandra Zanger, Raghuvir H. Gaonkar, Lisa McDougall, Francesco De Rose, Leila Jaafar-Thiel, Michael Herz, Matthias Eiber, Gary A. Ulaner, Wolfgang A. Weber and Melpomeni Fani

Journal of Nuclear Medicine September 2024, 65 (9) 1427-1434; DOI: https://doi.org/10.2967/jnumed.123.267126

Tais Basaco Bernabeu

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rosalba Mansi

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Luigi Del Pozzo

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sandra Zanger

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raghuvir H. Gaonkar

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa McDougall

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francesco De Rose

2Nuclidium AG, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leila Jaafar-Thiel

2Nuclidium AG, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Herz

3Department of Nuclear Medicine, Technical University of Munich, Munich, Germany;

4Bavarian Cancer Research Center, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eiber

3Department of Nuclear Medicine, Technical University of Munich, Munich, Germany;

4Bavarian Cancer Research Center, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gary A. Ulaner

5Molecular Imaging and Therapy, Hoag Family Cancer Institute, Irvine, California; and

6Departments of Radiology and Translational Genomics, University of Southern California, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang A. Weber

3Department of Nuclear Medicine, Technical University of Munich, Munich, Germany;

4Bavarian Cancer Research Center, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Melpomeni Fani

1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 9

September 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Journal of Nuclear Medicine Sep 2024, 65 (9) 1427-1434; DOI: 10.2967/jnumed.123.267126

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Journal of Nuclear Medicine Sep 2024, 65 (9) 1427-1434; DOI: 10.2967/jnumed.123.267126

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

PSMA
copper-61
prostate cancer
PET
theranostics

Main menu

User menu

Search

⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords